These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention. Mujugira A; Baeten JM; Donnell D; Ndase P; Mugo NR; Barnes L; Campbell JD; Wangisi J; Tappero JW; Bukusi E; Cohen CR; Katabira E; Ronald A; Tumwesigye E; Were E; Fife KH; Kiarie J; Farquhar C; John-Stewart G; Kidoguchi L; Panteleeff D; Krows M; Shah H; Revall J; Morrison S; Ondrejcek L; Ingram C; Coombs RW; Lingappa JR; Celum C; PLoS One; 2011; 6(10):e25828. PubMed ID: 21998703 [TBL] [Abstract][Full Text] [Related]
25. Pre-exposure prophylaxis for HIV prevention in women: current perspectives. Flash CA; Dale SK; Krakower DS Int J Womens Health; 2017; 9():391-401. PubMed ID: 28615975 [TBL] [Abstract][Full Text] [Related]
26. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Siegfried N; van der Merwe L; Brocklehurst P; Sint TT Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394 [TBL] [Abstract][Full Text] [Related]
27. Using a network-based approach and targeted maximum likelihood estimation to evaluate the effect of adding pre-exposure prophylaxis to an ongoing test-and-treat trial. Balzer L; Staples P; Onnela JP; DeGruttola V Clin Trials; 2017 Apr; 14(2):201-210. PubMed ID: 28124579 [TBL] [Abstract][Full Text] [Related]
28. CROI 2015: Advances in HIV Testing and Prevention Strategies. Buchbinder SP; Liu AY Top Antivir Med; 2015; 23(1):8-27. PubMed ID: 25965309 [TBL] [Abstract][Full Text] [Related]
29. Strategies used by gay male HIV serodiscordant couples to reduce the risk of HIV transmission from anal intercourse in three countries. Bavinton BR; Prestage GP; Jin F; Phanuphak N; Grinsztejn B; Fairley CK; Baker D; Hoy J; Templeton DJ; Tee BK; Kelleher A; Grulich AE; J Int AIDS Soc; 2019 Apr; 22(4):e25277. PubMed ID: 30983155 [TBL] [Abstract][Full Text] [Related]
30. Pre-Exposure Prophylaxis for HIV: Evidence and Perspectives. Nikolopoulos GK; Christaki E; Paraskevis D; Bonovas S Curr Pharm Des; 2017; 23(18):2579-2591. PubMed ID: 28356043 [TBL] [Abstract][Full Text] [Related]
31. Adolescent pre-exposure prophylaxis for HIV prevention: current perspectives. Machado DM; de Sant'Anna Carvalho AM; Riera R Adolesc Health Med Ther; 2017; 8():137-148. PubMed ID: 29238237 [TBL] [Abstract][Full Text] [Related]
32. Antiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxis. Krakower DS; Jain S; Mayer KH Curr HIV/AIDS Rep; 2015 Mar; 12(1):127-38. PubMed ID: 25600106 [TBL] [Abstract][Full Text] [Related]
33. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490 [TBL] [Abstract][Full Text] [Related]
34. Biomedical Approaches to HIV Prevention in Women. Heumann CL Curr Infect Dis Rep; 2018 Apr; 20(6):11. PubMed ID: 29666937 [TBL] [Abstract][Full Text] [Related]
35. Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa. Heffron R; Ngure K; Odoyo J; Bulya N; Tindimwebwa E; Hong T; Kidoguchi L; Donnell D; Mugo NR; Bukusi EA; Katabira E; Asiimwe S; Morton J; Morrison S; Haugen H; Mujugira A; Haberer JE; Ware NC; Wyatt MA; Marzinke MA; Frenkel LM; Celum C; Baeten JM; Gates Open Res; 2017; 1():3. PubMed ID: 29355231 [No Abstract] [Full Text] [Related]
36. Is PrEP necessary during natural conception in HIV-1-serodiscordant couples on ART with suppressed viral load? A retrospective cohort analysis. Sun L; Liu A; Li J; Shao Y; Li Q; Ye J; Zhang H; Li Z; Wang H BMC Infect Dis; 2020 Mar; 20(1):195. PubMed ID: 32138673 [TBL] [Abstract][Full Text] [Related]
37. Serodiscordant partnerships and opportunities for pre-exposure prophylaxis among partners of women and men living with HIV in St. Petersburg, Russia. Gnatienko N; Wagman JA; Cheng DM; Bazzi AR; Raj A; Blokhina E; Toussova O; Forman LS; Lioznov D; Bridden C; Sullivan M; Bryant K; Samet JH; Tsui JI PLoS One; 2018; 13(11):e0207402. PubMed ID: 30444903 [TBL] [Abstract][Full Text] [Related]
38. Attitudes of serodiscordant couples towards antiretroviral-based HIV prevention strategies in Kenya: a qualitative study. Fowler N; Arkell P; Abouyannis M; James C; Roberts L AIDS Patient Care STDS; 2015 Jan; 29(1):33-42. PubMed ID: 25375792 [TBL] [Abstract][Full Text] [Related]
39. Attitudes of serodiscordant couples towards antiretroviral-based HIV prevention strategies in Kenya: a qualitative study. Fowler N; Arkell P; Abouyannis M; James C; Roberts L J Int AIDS Soc; 2014; 17(4 Suppl 3):19563. PubMed ID: 25394070 [TBL] [Abstract][Full Text] [Related]